Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: A severe fatty acid oxidation disorder

European Journal of Pediatrics

Volumn 153, Issue 10, 1994, Pages 745-750

  Sewell, A C ^a   Bender, S W ^b   Wirth, S ^c   Munterfering H ^d   Ijlist, L ^e   Wanders, R J A ^e  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e University Children's Hospitals   (Netherlands)

Author keywords

3 Hydroxyacyl CoA dehydrogenase deficiency; Cardiomyopathy; Fatty acid oxidation; Hypoketotic hypoglycaemia

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; 3 HYDROXYDICARBOXYLIC ACID; ACYLCARNITINE; CARNITINE; UNCLASSIFIED DRUG;

ARTICLE; CARDIOMYOPATHY; CELL CULTURE; ENZYME DEFICIENCY; FATALITY; FATTY ACID OXIDATION; FIBROBLAST; HUMAN TISSUE; HYPOGLYCEMIA; INBORN ERROR OF METABOLISM; LIVER DISEASE; PRIORITY JOURNAL; URINARY EXCRETION;

3-HYDROXYACYL COA DEHYDROGENASES; CARNITINE; CASE REPORT; ENZYME TESTS; FATAL OUTCOME; HUMAN; HYPOGLYCEMIA; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; LIVER DISEASES; MALE; MITOCHONDRIAL MYOPATHIES; MYOCARDIAL DISEASES;

EID: 0027971063     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/BF01954492     Document Type: Article

References (35)

1. Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency
2. Human liver long-chain 3-hydroxyacyl-coenzyme A dehydrogenase is a multifunctional membrane-bound beta-oxidation enzyme of mitochondria
3. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation
4. Pathophysiological approach to carnitine palmitoyltransferase II deficiencies
5. Progressive neuropathy and recurrent myoglobinuria in a child with longchain 3-hydroxyacyl-coenzyme A deficiency
6. 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment
7. The existence of two different L-3-hydroxyacyl-coenzyme A dehydrogenases in rat tissues
8. Long-chain acylcarnitine increases intracellular Ca++ and induces after depolarisation in adult ventricular myocytes
9. 3-Hydroxydecanedioic acid and related homologues: urinary metabolites in ketoacidosis
10. 3-Hydroxydicarboxylic aciduria — a fatty acid oxidation defect with severe prognosis
11. Fatty acid oxidation disorders: a new class of metabolic diseases
12. Long-chain acyl coenzyme A dehydrogenase deficiency. An inherited cause of nonketotic hypoglycemia
13. The L-3-hydroxyacyl-CoA dehydrogenase deficiency
14. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
15. Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency — diagnosis, plasma carnitine fractions and management in a further patient
16. Differential diagnosis of hydroxydicarboxylic aciduria based on release of3H2O from [9, 10-3H] myristic and [9, 10-3H] palmitic acids by intact cultured fibroblasts
17. Clinical and biochemical presentations in 20 cases of hydroxydicarboxylic aciduria
18. 3-Hydroxydicarboxylic aciduria: a distinctive type of intermittent dicarboxylic aciduria of possible diagnostic significance
19. Familial hypoketotic hypoglycaemia associated with peripheral neuropathy, pigmentary retinopathy and C6–C14 hydroxydicarboxylic aciduria. A new defect in fatty acid oxidation?
20. Fatal outcome in a patient with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
21. Medium- and long-chain dicarboxylic aciduria in patients with Zellweger syndrome and neonatal adrenoleukodystrophy
22. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood
23. 4-Hydroxycyclohexanecarboxylic acid: a rare compound in urinary organic acid analysis
24. A new case of short-chain acyl-CoA dehydrogenase deficiency with isolated ethylmalonic aciduria
25. Plasma and mitochondrial membrane carnitine transport defects
26. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycaemia and low carnitine levels
27. Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome
28. Fatty acid β-oxidation in leukocytes from control subjects and medium-chain acyl-CoA dehydrogenase deficient patients
29. Long-chain 3-hydroxyacyl-CoA dehydrogenase in leukocytes and chorionic villus fibroblasts: potential for pre- and postnatal diagnosis
30. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid β-oxidation
31. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: different clinical expression in three unrelated patients
32. Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid oxidation
33. Comparison between the formation and the oxidation of dicarboxylcarnitine esters in rat liver and skeletal muscle: possible implications for human inborn disorders of mitochondrial β-oxidation
34. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency